Topic:Influenza
Equine influenza is a highly contagious respiratory disease caused by influenza A viruses, specifically affecting horses. The disease is characterized by symptoms such as fever, coughing, nasal discharge, and lethargy. Transmission occurs primarily through aerosolized droplets and direct contact, leading to rapid spread among susceptible populations. Vaccination is a common preventive measure, though the virus's ability to mutate necessitates ongoing surveillance and vaccine updates. This page gathers peer-reviewed research studies and scholarly articles that explore the virology, epidemiology, clinical presentation, and management strategies of equine influenza, with a focus on its impact on equine health and welfare.
A three-year evaluation of four commercial equine influenza vaccines in ponies maintained in isolation. Ponies held in isolation for 40 months were vaccinated and revaccinated with four commercial equine influenza vaccines. Little or no HI antibody was detected after the first inoculation; second and subsequent annual revaccinations produced peak HI antibody titres between 7 and 14 days. Titres fell quickly between 14 and 28 days and less quickly thereafter. The decline of HI antibody appeared to be related more to the initial titre attained and to the period after vaccination than to the composition of the vaccine. The response to a first annual revaccination was superior to that produced by a ...
The outbreak of equine influenza in England: January 1976. Equine influenza type 2 infections occurred in the Newmarket areas in January 1976. The disease did not spread to any extent and while this may have been due to recent vaccination it was found that not all vaccinated horses were fully protected. The virus involved showed some antigenic drift from the prototype strain A/equine/Miami/1/63 (Heq 2 Neq 2).
Infectious causes of equine respiratory disease on Ontario standardbred racetracks. Upper respiratory disease has been a serious problem in Standardbred horses on racetracks in Ontario, with outbreaks occurring once or twice annually in late winter and early spring seasons. To determine the causes of these epidemics, a 3-year investigation was carried out in which nasal swabs and serum samples were obtained at intervals from apparently healthy horses and from horses suffering from upper respiratory disease. The nasal swabs were used to isolate bacteria and viruses. The serum samples were examined for the presence and level of antibodies to equine influenza viruses and equine ...
[Outbreak of equine influenza by a new strain of Myxovirus type 2. II. Epizootiology]. During an epizootic of equine acute respiratory disease in Algeria, a strain of equine influenza virus was isolated. Sera examination by hemagglutinin inhibition test and complement fixation test confirmed the etiology of the disease. The first and second outbreak of the disease remained localised. The third outbreak spread within few months to all parts of the country. Horses vaccinated with a commercial equine influenza vaccine remained healthy.
[Influenza vaccination: which vaccine (author’s transl)]. A comparative study of the literature of the past ten years showed that vaccination of horses and ponies against influenza is best done using adjuvant-containing vaccines. Comparable results may probably be obtained by twice inoculating an aquenous vaccine. There are no drawbacks to the use of aluminium-hydroxide as an adjuvant when mineral oil is used as an adjuvant, the first and second vaccinations do not present any problems.
Sero-epidemiological study on equine influenza in Japan. A serological survey was conducted on horse sera collected for 7 years just before the first outbreak of equine influenza (EI) infection in Japan in 1971. No antibodies against the A/Equi-1/Prague/56 (equi-1) and A/Equi-2/Miami/63 (equi-2) strains of EI virus were detected in any of the sera of 452 native horses when employing hemagglutination inhibition (HI) and complement fixation (CF) tests against viral (V) antigen. On the contrary, of the 80 imported horses, 48 (60.0%) had HI titers of 1:8 or higher against equi-1 and 23 (28.8%) against equi-2. In the CF-V test 42.6% of the horses showed ...
[Preparative isolation of alpha 2-macroglobulin, transferrin, albumin and study of their nonspecific gamma-inhibitory activity]. Profiles of distribution of non-specific gamma-inhibitors of influenza A2/Victoria/35/72 in donkey and horse sera were established by gel chromatography in Sephadex G-200. High and low molecular inhibitors were found in 19S and 4S serum fractions. Highly purified preparations of a2-macroglobulin, transferrine and albumin were isolated by a combination of methods of salt precipitation, gel chromatography on Sephadex G-100, G-200 and ion exchange on DEAE-Sephadex A-50. Heating sera resulted in a considerable increase of the antiviral activity of a2-macroglobulin and transferrine and a reduction ...
Experience of the efficacy of equine influenza vaccinations. In 1974, a very extensive influenza/A/equi 2 epidemic broke out in the Finnish horse population. To study the efficacy of influenza vaccinations a questionnaire was sent after the epidemic to all Finnish veterinarians. The answer material was selected to contain only stables which had had clinically typical cases. The material consisted 234 unvaccinated and 629 vaccinated horses. In the latter group 466 horses were vaccinated adequately. The results of the study showed that of the unvaccinated horses 212 (91%) and of the adequately vaccinated horses only 42 (9.4%) contracted clinically typical...
Immunization of man and animals against influenza by oral and intranasal routes. Live human and equine influenza virus strains modified by serial passage on allantois-on-shell system (AOS) in the presence of normal horse serum were administered orally or intranasally to volunteers or horses. Mostly mild clinical short-lasting reactions, replication in nasal mucosae, transmission to placebo recipients and significant local or circulating antibody rises were observed following administration to volunteers of strains modified by five or less serial passages on AOS in the presence of normal horse serum (NHS). Milder clinical reactions, no replication, no viral transmission and...
[Equine influenza in Czechoslovakia during the 1973 epizootic]. During the epizootic spreading in Europe, equine influenza was brought in also into Czechoslovakia. The disease gradually spread from Slovakia (where horses were isolated after a trip abroad) to race horses throughout the country. The serological examination by the IH test showed that, again, the A equi 1/Praha 56 virus was the causative agent of the infection. The application of the Grippeguin vaccine from France was effective. No clinical manifestations of the disease were observed in two mares from one farm that had not been vaccinated although they had been in the focus of infection. Howev...
Equine infectious respiratory disease. During the past 20 years the equine population of Great Britain and Ireland has increased with the result that the practising veterinary surgeon is more frequently called upon to advise on equine problems. A significant portion of this advice is concerned with the examination of horses showing signs of this advice is concerned with the examination of horses showing signs of respiratory disease. Numerous pathogens, which include viruses, bacteria, parasites and moulds invade the respiratory tract causing similar signs of illness. It is therefore difficult to provide an aetiological diagnosis ba...
[Contribution to the antigenic study of influenza viruses in animals. I.–Neuraminidase of the equine influenza viruses (author’s transl)]. From the Revised Nomenclature of WHO, the fowl influenza virus A/Duck/Ukraine/63 (Hav7 Neq2) has the same neuraminidase as the equine virus A/equi 2/Miami/63 (Heq2 Neq2); the A/Chicken Germany "N"/49 virus has the same neuraminidase as the equine virus A/equi 1/Prague/56. A comparative study of the antigenic specificities confirms that the Neq2 neuraminidases are closely connected, whatever their animal origin, and that the fowl strain Hav7 Neq2 can be used for the titration of anti Neq2 antibodies in the serums of animals immunized with the equine virus Heq2 Neq2. The Neqi neuraminidases of v...
[Contribution to the antigenic study of influenza viruses in animals. II.–Antibodies, antineuraminidase in horse: conditions of apparition and importance (author’s transl)]. In the first part of this paper the conditions for a specific titration of antibodies against the neuraminidase (N) of each of the two horse virus subtypes are defined. The antigens used are: the H72Neq 1 recombining agent to measure the anti Neq1 antibodies and the A/Duck/Ukraine/63 strain for the anti Neq2 antibodies. The immunity response to neuraminidase appears after the natural disease; this response is studied in two foci, one due to a virus belonging to the A equi I subtype (Loire 73 strain), the other to a virus of the A equi 2 subtype (SHN 73 strain). The kinetics of apparition of an...
Comparison of SN and HI antibody dose response curves in chickens, rabbits, foals and horses following vaccination with equine influenza vaccine. After vaccination of chickens, rabbits, foals and horses, HI and SN antibody dose response curves were compared for A/Equi 1/Prague and A/Equi 2/Paris strains.
The two curves are parallel for a given strain and the relationship of HI and SN titres is constant, whatever the animal species.
The distribution of HI and SN titres varies for the two strains.
This variation, which is independent of animal species, may be related to the number of sites necessary for the antigenic-antibody response in vitro.
It is suggested that the testing of equine influenza vaccine be carried out in the ...